Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
This study uses data from the 2019 to 2022 cycles of the National Health Interview Survey to estimate the prevalence of type 1 diabetes among…
This study uses data from the 2019 to 2022 cycles of the National Health Interview Survey to estimate the prevalence of type 1 diabetes among…
This cross-sectional study assesses whether the rates and trends of psychotropic medication prescribing changed from before vs in the 2 years after the onset of…
This case series examines the cases and hospitalizations of children due to COVID-19 in California following eligibility by age group for SARS-CoV-2 vaccination.
This case-control study examines the extent to which caregivers with Medicaid coverage whose children were referred to child protective services as at risk of maltreatment…
This cohort study assesses the association between severe maternal morbidity after a first delivery and risk of hospitalization or emergency department (ED) visits for a…
PURPOSE Biliary tract cancers (BTCs) are aggressive cancers that carry a poor prognosis. An enhanced understanding of the immune landscape of anatomically and molecularly defined…
This cohort study examines the association between surgeon-patient sex discordance and postoperative outcomes.
Background Oncogenic BRAF mutations can be categorized into three classes (I, II and III) based on their distinct structural and signaling properties. BRAF inhibitors are…